Fingerprint
Dive into the research topics of 'Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study
Wilson X. Wang, Dan Spiegelman, P. Kumar Rao, Andria L. Ford, Rajendra S. Apte
- Department of Ophthalmology and Visual Sciences
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Department of Neurology
- Section of Stroke & Cerebrovascular Diseases
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Neurosciences
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Center of Regenerative Medicine
Research output: Contribution to journal › Article › peer-review